🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Research Progress on the Correlation between Hypertension and Polycythemia Vera
Abstract:Polycythemia Vera (PV) is a myeloproliferative neoplasm characterized by clonal erythrocytosis with mutations in the tyrosine kinase 2 gene. Its clinical features include headache, dizziness, increased red blood cell count, and thrombosis. Hypertension is also a common symptom of PV and a risk factor for thrombosis in PV patients [1]. It has been reported that 39% to 70% of PV patients have comorbid hypertension, and hypertension combined with cerebrovascular events and other cardiovascular complications is a common cause of death in PV patients, accounting for approximately 45% of total causes of death [2-3].
Keywords:HypertensionPolycythemia VeraHypertensionRenal vascularSecondary hypertensionDrug-induced hypertension
Publication Date:2025-05-15
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:3( 683-685 )